Typically, the diagnosis is based on medical history and neurological examination conducted by interviewing and observing the patient in person using the Unified Parkinson's Disease Rating Scale. A radiotracer for SPECT scanning machines called DaTSCAN and made by General Electric is specialized for diagnosing Parkinson's Disease, but it is only marketed in Europe. Due to this, the disease can be difficult to diagnose accurately, especially in its early stages.
Due to symptom overlap with other diseases, only 75% of clinical diagnoses of PD are confirmed to be idiopathic PD at autopsy.
Early signs and symptoms of PD may sometimes be dismissed as the effects of normal aging. The physician may need to observe the person for some time until it is apparent that the symptoms are consistently present. Usually doctors look for shuffling of feet and lack of swing in the arms.
Doctors may sometimes request brain scans or laboratory tests in order to rule out other diseases. However, CT and MRI brain scans of people with PD usually appear normal.
Clinical practice guidelines introduced in the UK in 2006 state that the diagnosis and follow-up of Parkinson's disease should be done by a specialist in the disease, usually a neurologist or geriatrician with an interest in movement disorders.
Related Post
- Vitamin C helps identify more aggressive or treatment resistant tumours
- U.S. physicians spend more time, money for interaction with health plans than Canadian doctors
- Roadmap to Overcome Obstacles for Using Induced Pluripotent Stem Cells
- EPO Issues European Patent for Rexahn's Neurotherapeutic compositions
- Human Brain Cells Created from Skin Cells: Potential for Alzheimer’s
- Parkinson's Disease Support
- Parkinson's Disease Treatment
- Parkinson's Disease Research
- Parkinson's Disease Pathophysiology
- Parkinson's Disease Prognosis